The Pennant Group’s first quarter was met with a positive market response as the company’s non-GAAP profit exceeded expectations, despite revenue coming in slightly below analyst forecasts. Management attributed the quarter’s performance primarily to operational improvements within newly acquired businesses, ongoing integration in the Southeast, and margin stability across both the Home Health and Senior Living segments. CEO Brent Guerisoli highlighted the company’s ability to rebound from seasonal and weather-related disruptions, noting, “We have successfully rebounded and increased total census above the levels at the time of acquisition.” Leadership development and local operational autonomy were also emphasized as key drivers of ongoing margin improvement.

Is now the time to buy PNTG? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From The Pennant Group’s Q1 Earnings Call

• Brian Tanquilut (Jefferies) asked about the cadence of integration and margin impact from Southeast acquisitions. President John Gochnour emphasized that transition service agreement costs should fall as integration concludes and systems adoption accelerates.
• Raj Kumar (Stephens) questioned the drivers behind strong same-store Medicare admissions. Gochnour explained that local market execution and being the preferred provider have enabled Pennant to win share in a shifting competitive landscape.
• David MacDonald (Truist) inquired about payer negotiations and the impact of regulatory focus on fraud and abuse. CEO Brent Guerisoli described positive progress with national payers and suggested increased industry scrutiny could open new opportunities for compliant providers.
• Benjamin Hendrix (RBC Capital Markets) asked about hospice CAP management in competitive markets. Management acknowledged pressures in high-reimbursement states like California but pointed to robust tracking systems and local best practices as key mitigation tools.
• Jared Haase (William Blair) sought clarity on same-store margin improvement levers. Gochnour cited efficiency gains from technology, better care planning, and operating leverage as main contributors.

Catalysts in Upcoming Quarters

In future quarters, our analyst team will monitor (1) the pace and effectiveness of Southeast integration, particularly as transition service costs decline, (2) improvements in occupancy and margin recovery in newly acquired Senior Living communities, and (3) the impact of evolving payer contracts and joint ventures on revenue mix. Execution on these milestones and the ability to sustain operational discipline during regulatory scrutiny will be crucial for tracking Pennant’s progress.

The Pennant Group currently trades at $35.36, up from $32.53 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.